| Dec'18 | Dec'17 | |||||
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net income | ||||||
2,257 | 337 | |||||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Realized loss from sale of investment | ||||||
-97 | - | |||||
Interest earned on investment held in Trust Account | ||||||
3,767 | 422 | |||||
Changes in current assets and current liabilities: | ||||||
Prepaid assets | ||||||
- | 59 | |||||
Accounts payable and accrued expense | ||||||
771 | 15 | |||||
Due to related parties | ||||||
14 | 4 | |||||
Net cash used in operating activities | ||||||
-625 | -124 | |||||
Cash Flows from Investing Activities: | ||||||
Principal deposited in Trust Account | ||||||
- | 206,362 | |||||
Proceeds from sales and redemptions of investment held in Trust Account | ||||||
626,140 | 179,999 | |||||
Purchase of investment held in Trust Account | ||||||
626,140 | 179,999 | |||||
Net cash used in investing activities | ||||||
- | -206,362 | |||||
Cash Flows from Financing Activities: | ||||||
Proceeds from initial public offering, net of underwriters' fees | ||||||
- | 202,235 | |||||
Proceeds from private placement | ||||||
- | 5,277 | |||||
Proceeds from underwriter's unit purchase option | ||||||
- | 0 | |||||
Proceeds from sale of ordinary shares to initial shareholders | ||||||
- | 31 | |||||
Proceeds from Sponsor loan | ||||||
500 | 500 | |||||
Repayment of Sponsor loan | ||||||
- | 578 | |||||
Repayment of advances from related party | ||||||
- | 84 | |||||
Payments of deferred offering costs | ||||||
- | 727 | |||||
Net cash provided from financing activities | ||||||
500 | 206,653 | |||||
Net (Decrease) Increase in Cash | ||||||
-125 | 165 | |||||